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Group II nonproteolytic Clostridium botulinum (gIICb) are an important concern for the safety of 15 
minimally processed ready-to-eat foods, because they can grow and produce botulinum 16 
neurotoxin during refrigerated storage. The principles of control of gIICb by conventional food 17 
processing and preservation methods have been well investigated and translated in guidelines for 18 
the food industry but in contrast, the effectiveness of emerging processing and preservation 19 
techniques has been poorly documented. The reason is that experimental studies with C. 20 
botulinum are cumbersome because of biosafety and biosecurity concerns. In the present work, 21 
we report the construction of two nontoxigenic derivatives of the type E gIICb strain NCTC 22 
11219. In the first strain, the botulinum toxin gene (bont/E) was insertionally inactivated with a 23 
retargeted intron using the ClosTron system. In the second strain, bont/E was exchanged for an 24 
erythromycin resistance gene using a new gene replacement strategy that makes use of pyrE as a 25 
bidirectional selection marker. Growth under optimal and stressed conditions, sporulation 26 
efficiency and spore heat resistance of the mutants were unaltered except for a small difference in 27 
spore heat resistance at 70 °C and in growth at 2.3% NaCl. The mutants described in this work 28 
provide a safe alternative for basic research as well as for food challenge and process validation 29 
studies with gIICb. In addition, this work expands the clostridial genetic toolbox with a new gene 30 
replacement method that can be applied to replace any gene in gIICb and other clostridia. 31 
IMPORTANCE 32 
The nontoxigenic mutants described in this work provide a safe alternative for basic research as 33 
well as for food challenge and process validation studies with psychrotrophic Clostridium 34 
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botulinum. In addition, this work expands the clostridial genetic toolbox with a new gene 35 
replacement method that can be applied to replace any gene in clostridia. 36 




Botulism is a rare but severe paralytic illness in humans and animals, caused by the botulinum 39 
neurotoxin (BoNT) produced by Clostridium botulinum. Botulinum toxins are 150 kDa proteins 40 
with zinc endopeptidase activity, consisting of two subunits, a 100 kDa heavy chain and a 50 kDa 41 
light chain. The heavy chain is responsible for binding and translocation of the light chain into 42 
the cytosol of neuronal cells, whereas the light chain cleaves SNARE proteins that are involved 43 
in docking of acetylcholine-containing vesicles and fusion to the presynaptic membrane. When 44 
the SNARE proteins are cleaved, neurotransmitter release is inhibited, leading to paralysis of the 45 
corresponding muscle (1, 2).  46 
C. botulinum is a strictly anaerobic bacterium that thrives in decaying organic matter in soils and 47 
sediments of ponds, lakes and oceans. It also forms dormant endospores that are highly resilient 48 
to hostile conditions and therefore can be found widespread in the environment. These spores 49 
may contaminate foods via the raw materials or other sources, possibly leading to foodborne 50 
botulism when they are not eliminated by processing and when their outgrowth is not controlled 51 
(3, 4, 5, 6, 7). C. botulinum is divided into four distinct groups (I to IV) based on phylogenetic 52 
and physiological characteristics, of which only group I and II are typically associated with 53 
human botulism. Group I C. botulinum consists of proteolytic mesophilic strains producing toxin 54 
types A, B and/or F. These strains form heat resistant spores and are the main target for the so-55 
called “botulinum cook”, the process used in canning of low acid foods (121 °C/3 min or 56 
equivalent). Group II C. botulinum (gIICb) comprises nonproteolytic strains producing toxin 57 
types B, E or F, which are saccharolytic, psychrotrophic (with minimum growth temperatures of 58 
3 °C) and whose spores are less heat resistant than those of group I (8). In the food industry, 59 
gIICb is a major concern for the safety of minimally processed chilled ready-to-eat foods with an 60 
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extended shelf life (REPFEDs), because spores surviving the mild processing treatments may 61 
subsequently germinate, grow out and produce toxin during refrigerated storage (6, 7, 9, 10, 11). 62 
The combination of the heat resistance of its spores and the ability to grow under refrigeration 63 
conditions makes this pathogen to be the main target pathogen that must be controlled in these 64 
foods. Guidelines for control of this hazard in the food industry have been developed more than 65 
two decades ago, requiring either a 6-decimal (6-D) reduction of the spores by heat treatment (90 66 
°C/10 min or equivalent), or control of outgrowth by limitation of the refrigerated storage time to 67 
< 10 days, inclusion of ≥ 3.5% NaCl, ≥ 100 ppm nitrite, acidifying to pH ≤ 5.0 or an appropriate 68 
combination of these or additional hurdles (11, 12). However, the increasing consumer’s demand 69 
for fresh-tasting healthy ready-to-eat foods that have been minimally processed, contain less salt 70 
and no artificial preservatives, yet have a long shelf-life, represent a challenge for the food 71 
industry in view of these botulinum safety guidelines (10, 11, 12). Furthermore, novel food 72 
processing and preservation technologies (e.g. high pressure or pulsed electric field treatment, 73 
natural preservatives) have found their way to commercial food production, but data regarding 74 
their efficiency to control gIICb is scarce or lacking (13, 14, 15, 16, 17). This is in sharp contrast 75 
to the attention given in this context to other pathogens like Listeria monocytogenes, Salmonella, 76 
enterohemorrhagic Escherichia coli. The main reason for this paucity of data is that C. botulinum 77 
studies are subject to important biosafety and bioterrorism restrictions, and because their culture 78 
requires strict anoxic conditions. One possible approach to circumvent these difficulties is the use 79 
of nonpathogenic surrogate organisms. For example, C. sporogenes has been widely used as a 80 
surrogate for proteolytic C. botulinum in the studies on thermal processing of low-acid shelf-81 
stable foods (18). However, a suitable validated surrogate for gIICb is lacking up to date. 82 
Recently, Parker et al. (19) studied previously isolated natural nontoxigenic Clostridium spp. that 83 
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could possibly be used as surrogates for gIICb. Two out of the three strains analysed showed 84 
equal or faster growth than toxigenic gIICb under most (but not all) stress conditions (low 85 
temperature, reduced pH and aw), making them potentially useful for challenge studies with 86 
refrigerated foods, at least under some conditions. However, the spores of the three strains had 87 
lower heat resistance than some gIICb strains, and thus could not be used for validation of 88 
heating processes. Furthermore, it could not be excluded that the strains still carried bont or other 89 
toxin genes, and the (phylo)genetic relatedness of the strains to gIICb was not documented. This 90 
makes the behaviour of the strains under other than the tested environmental conditions 91 
unpredictable (e.g. sensitivity to nitrite and other preservatives, sensitivity to organic acids…).  92 
As an alternative approach to develop safe strains for challenge studies and process validation, 93 
we attempted in the present work to construct nontoxic derivatives from a toxic gIICb strain by 94 
making a targeted knockout of the bont gene. The resulting derivative strains are then expected to 95 
differ from their parent only in toxin production, and thus to be a highly reliable alternative for 96 
challenge studies. Although the inactivation of specific genes in clostridial species has proven to 97 
be a rather difficult, slow and inefficient task for a long time, the genetic toolbox for knockout 98 
mutagenesis has been expanding the last few years. The ClosTron system, which makes use of a 99 
mobile intron that can be retargeted to a sequence of interest, has proven to be particularly 100 
efficient for insertional mutagenesis in a range of clostridial species (20), but only a few studies 101 
have used ClosTron mutagenesis in gIICb thus far (21, 22). Interestingly ClosTron has been used 102 
to knockout the bont gene both in gICb and gIICb (21, 23), but the properties of the gIICb 103 
knockout strain in view of its possible usefulness for challenge or process validation studies in 104 
foods were not further investigated. Importantly, a disadvantage of ClosTron mutagenesis is that 105 
reversion to the toxigenic state by excision of the intron from the bont gene cannot be excluded. 106 
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For this reason, we additionally developed a method for bont deletion that makes use of pyrE, a 107 
gene encoding the enzyme orotate phosphoribosyltransferase which is required for de novo uracil 108 
biosynthesis. This gene has been used before in various clostridia (C. sporogenes, C. difficile, C. 109 
acetobutylicum) as a positive/negative selection marker. PyrE is essential for growth in the 110 
absence of uracil, while cells lacking PyrE become resistant to 5-fluoroorotic acid (5-FOA), a 111 
substrate analogue in de novo uracil biosynthesis that is converted to a toxic product. Therefore, 112 
cells encoding pyrE can be selected on uracil-free medium or counterselected in the presence of 113 
5-FOA (24, 25, 26). We used this bidirectional selection to delete bont/E and replace it by an 114 
erythromycin resistance cassette. This is the first report of a targeted gene deletion in gIICb. In 115 
addition, our gene replacement strategy is novel in that it allows a single-step selection of gene 116 
replacement by double homologous recombination and loss of the plasmid on which the donor 117 
DNA is supplied. 118 
MATERIAL AND METHODS 119 
Bacterial strains and growth conditions 120 
Cultures of C. botulinum type E NCTC 11219 (obtained from National Collection of Type 121 
Cultures, Public Health England) were routinely grown at 30 °C in trypticase peptone glucose 122 
yeast extract broth (TPGY; 50 g/l trypticase (BD), 5 g/l bacteriological peptone (Oxoid), 20 g/l 123 
yeast extract (Oxoid), 4 g/l glucose, 1 g/l sodium thioglycollate) and plated on reinforced 124 
clostridial medium (RCM (VWR), 37 g/l RCM + 15 g/l agar), TPGY agar (TPGY broth + 15 g/l 125 
agar) or tryptone yeast extract thioglycollate agar (TYG; 30 g/l tryptone (Lab M), 20 g/l yeast 126 
extract, 1 g/l sodium thioglycollate, 15 g/l agar). Trypticase glucose yeast broth (Bio-Rad) 127 
supplemented with 0.1% trypsin (Life Technologies) was used to grow cultures for the mouse 128 
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bioassays. Uracil-deficient medium was accomplished by replacing yeast extract in TPGY agar 129 
with 20 g/l Acid Hydrolysed Casein (Lab M) (27). Clostridial vegetative cultures were 130 
manipulated and incubated in a Whitley DG250 anaerobic workstation (initial gas mixture 131 
comprised of 80% N2, 10% CO2, and 10% H2) using overnight pre-reduced media. E. coli strains 132 
were grown in lysogeny broth (LB; 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl) or on LB agar 133 
(LB + 15 g/l agar) at 37 °C. E. coli DH5α was used for cloning and maintenance of plasmids, 134 
while E. coli CA434 (HB101 containing plasmid R702, (28)) was used as conjugation donor. 135 
Media were supplemented with the following antibiotics (Applichem): thiamphenicol (Tm, 15 136 
μg/ml in agar, 7.5 μg/ml in broth) and erythromycin (Em, 2.5 μg/ml) for C. botulinum, and 137 
cycloserine (Cy, 250 μg/ml) and chloramphenicol (Cm, 25 μg/ml in agar, 12.5 μg/ml in broth) for 138 
E. coli. 5-Fluoroorotic acid (5-FOA, 500 µg/ml (Manchester Organics)) was used for the 139 
screening of uracil auxotrophs. 140 
Sporulation and purification of spore crops 141 
Spore crops were prepared using a two-phase sporulation medium as described before, with 142 
minor adjustments (29). First, a single colony was inoculated in 1 mL TPGY broth at 30 °C. 143 
After 24h of growth, this culture was added to a two-phase medium consisting of 4 mL distilled 144 
deoxygenated water over solid sporulation medium (3 g cooked meat medium (Oxoid), 0.03 g 145 
glucose, 0.45 g agar in 30 mL water). Spores were harvested from the liquid phase after 6 days 146 
incubation at 30 °C by centrifugation (3400 × g, 4 °C, 15 min). The resulting pellet was washed 147 
four times with 0.85% sterile saline by centrifugation, concentrated fivefold and stored in saline 148 
at 1-4 °C outside the anaerobic workstation. 149 
  150 
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Construction of plasmids 151 
The ClosTron technology was used for the generation of an insertion mutant. This system is 152 
based on retargeting a bacterial group II intron to insert in a gene of interest (20, 30). Possible 153 
target sites in the bont/E gene of C. botulinum NCTC 11219 were identified using an intron 154 
design tool on the ClosTron website (www.clostron.com), and one site was chosen based on a 155 
high score according to the algorithm as well as proximity to the N-terminus of the toxin. The 156 
plasmid pMTL007C-E2:Cbo:bontE-211a, containing the intron flanked by the specific targeting 157 
sequences (GGTCATAATAACTACTATCTCCATTTTTTA<intron>CTAATTATTTACAAA) 158 
was obtained from DNA 2.0 Inc. (Menlo Park, California, USA). 159 
The second knockout strategy consisted of an allelic exchange of bont/E with ermB, an Em 160 
resistance gene. A novel three-step strategy was designed, with each step requiring a specific 161 
plasmid construct. Oligonucleotide primers used in these constructions are listed in Table 1 and 162 
were obtained from Integrated DNA Technologies (Heverlee, Belgium). Constructs were 163 
routinely transferred to E. coli DH5α by electroporation and verified by sequencing before further 164 
use. The first plasmid construct was used to generate a pyrE deletion (locus tag SR42_16845) in 165 
strain NTCT 11219. To this end, flanking loci of pyrE were cloned in pMTL84151 (31) to yield 166 
pMTL84151_pyr5’pyr3’. More specifically, the 5’ fragment (1086 bp) was amplified from 167 
genomic DNA (gDNA) of NCTC 11219 with primers pyrE_5’F/pyrE_5’R and the 3’ fragment 168 
(1164 bp) with primers pyrE_3’F/pyrE_3’R. Amplicons were restricted with respectively 169 
KpnI/BamHI, and BamHI/XhoI, ligated end-to-end in pMTL84151 opened with KpnI and XhoI, 170 
and electroporated to E. coli DH5α. Secondly, the plasmid pMTL84151_Δbont, used to replace 171 
bont/E for ermB was constructed as illustrated in Fig. 1. Flanking loci (5’ locus: 1080 bp; 3’ 172 
locus: 1261 bp) of bont/E were first cloned in pMTL84151, using primers bontE_5’F/bontE_5’R 173 
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and bontE_3’F/bontE_3’R for amplification. These loci include the first two codons of bont/E in 174 
the 5’ fragment and the last sixteen codons in the 3’ fragment. After restriction of the PCR 175 
products with respectively KpnI/BamHI and BamHI/XhoI, the 5’ and 3’ fragments were ligated 176 
end-to-end in pMTL84151 opened with KpnI and XhoI. Subsequently, ermB (amplified from 177 
pMTL82254 with pMTL82254ermB_F/pMTL82254ermB_R and restricted at both ends with 178 
BamHI) was inserted in the BamHI site of this plasmid, resulting in 179 
pMTL84151_5’bont_ermB_3’bont. In addition, wild type pyrE of NCTC 11219 (675 bp) was 180 
amplified from start to stop codon with primers pyrE11219_F/pyrE11219_R, restricted with 181 
NdeI/SacI and placed after promotor pfdx in pMTL83353 opened with the same enzymes. pfdx was 182 
used to drive pyrE expression because pyrE is located at the end of an operon in NCTC 11219 183 
and thus could not be simply amplified with its native promotor. Hereafter, the fragment 184 
containing pfdx and pyrE was amplified with pMTL83353_F/pyrE11219_R, digested with SbfI 185 
and SacI and cloned in pMTL84151_5’bont_erm_3’bont, restricted with the same enzymes. This 186 
resulted in the plasmid pMTL84151_Δbont. A third plasmid was designated 187 
pMTL84151_WTpyr, used for restoring the pyrE deletion back to wild type. This was created by 188 
cloning a pyrE amplicon with its 5’ and 3’ flanking regions (2956 bp) generated with primers 189 
pyrE_5’F/pyrE_3’R and restricted with KpnI and XhoI, into pMTL84151, cleaved with the same 190 
enzymes. In this construct, a promotor is absent thus pyrE is not expressed on the plasmid. 191 
Mating  192 
Each of the four plasmid constructs described above was introduced in E. coli CA434 by 193 
electroporation and selecting CmR transformants. For plasmid transfer to C. botulinum NCTC 194 
11219, one mL of an overnight LB culture of E. coli donor containing the appropriate plasmid 195 
was centrifuged, the pellet was washed with PBS (phosphate buffered saline, 8 g/l NaCl, 0.2 g/l 196 
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KCl, 1.44 g/l Na2HPO4, 0.24 g/l KH2PO4, pH adjusted with HCl to 7.4) and taken in the 197 
anaerobic workstation. Next, the pellet was resuspended in 200 µL of NCTC 11219 recipient 198 
grown for 24h in TPGY broth whereafter the mixture was spread on a cellulose acetate filter 199 
(poresize 0.45µm) on non-selective TYG agar. After 24h of incubation at 30 °C, the cells were 200 
washed off the filter with 1 mL PBS, and 200 µL was plated on selective RCM plates (Tm for 201 
resistance encoded on the plasmid, Cy against E. coli donor). Colonies appearing within 3 days 202 
were restreaked to purity on the same selective medium. 203 
  204 
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Isolation and verification of bont/E ClosTron insertion mutant 205 
To confirm transfer of the ClosTron plasmid pMTL007C-E2:Cbo:bontE-211a to NCTC 11219, 206 
TmR colonies were purified after mating and analysed by PCR using primers RAM_F/RAM_R. 207 
Subsequently, transconjugants were streaked on RCM supplemented with Em, and well-208 
developed colonies appearing within 3 days were restreaked on the same medium for 209 
purification. PCR and sequence analysis with primers bontE_F/bontE_R were performed to 210 
verify successful intron insertion in bont/E. Individual colonies from a verified clone were then 211 
screened for Tm sensitivity, indicating loss of the ClosTron plasmid, which was hereafter 212 
confirmed by PCR using primers pCD6_F/pCD6_R.  213 
To investigate whether only one insertion event took place, the Y-linker PCR described by Kwon 214 
& Ricke (32) was used. In this method, gDNA of the ClosTron mutant is restricted to completion 215 
with NlaIII and ligated to a Y-shaped linker, generated by mixing two oligonucleotides that are 216 
complementary only at one end. The complementary parts of these oligonucleotides form the 217 
stalk of the linker, which has a 3’ CATG overhang that stocks to the NlaIII chromosomal DNA 218 
ends. The non-complementary parts of the oligonucleotides form the Y-linker arms. PCR is then 219 
conducted on the ligation mixture with a ClosTron specific primer (ClosTron_R) and a Y-linker 220 
primer with a sequence identical, not complementary, to one of the arms. Only when the 221 
ClosTron_R primer extends DNA synthesis during the first PCR cycle into the Y-linker arm, the 222 
Y-linker primer can anneal and a PCR product will be formed. Consequently, the two primers 223 
selectively amplify all fragments in the genome containing the ClosTron insert.  224 
  225 
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Isolation and verification of bont/E deletion mutant  226 
After conjugation of pMTL84151-pyr5’pyr3’ to NCTC 11219, transconjugants were streaked on 227 
RCM supplemented with 5-FOA to select for PyrE deficient mutants generated by double 228 
homologous recombination between the plasmid-based pyrE-flanking fragments and the 229 
corresponding chromosomal sequences. Deletion was confirmed by PCR and sequence analysis 230 
with primers pyrE_5’Fb/pyrE_3’Rb, which anneal outside the homologous fragments involved in 231 
recombination. Further, a clone from which the plasmid was cured, was isolated by screening for 232 
Tm sensitivity. Next, NCTC 11219 ∆pyrE was mated with E. coli CA434 containing 233 
pMTL84151_Δbont. Transconjugants were streaked on RCM supplemented with Em and 5-FOA, 234 
to select for clones in which double homologous recombination as well as loss of the plasmid had 235 
occurred. Plasmid loss was confirmed by the Tm sensitivity of the clones. PCR and sequence 236 
analysis with primers upbontE_F/downbontE_R, annealing outside the homologous fragments, 237 
were performed to confirm that bont/E was deleted and replaced by ermB. Finally, the pyrE gene 238 
was restored to wild type by first conjugating pMTL84151-WTpyr to NCTC 11219 ∆pyrE 239 
∆bontE::ermB and subsequently propagating one transconjugant in liquid TPGY medium for 240 
about 60 generations and subsequently plating on uracil-deficient medium. Only clones in which 241 
the chromosomal pyrE gene is restored by allelic exchange with the plasmid-based promotorless 242 
pyrE grow well on these plates. One such clone, confirmed by PCR and sequence analysis to be 243 
identical to the wild type in the pyrE locus and from which the plasmid was cured as explained 244 
before, was isolated and designated NCTC 11219 ∆bontE::ermB.  245 
  246 
14 
 
Mouse bioassays 247 
Mouse bioassays were performed for detection of active botulinum toxin in clostridial cultures. 248 
The assays were performed with bont/E knockout strains NCTC 11219 bontE211a::CT and 249 
NCTC 11219 ΔpyrE ΔbontE::ermB, and with the corresponding positive control strains NCTC 250 
11219 wild type and NCTC 11219 ΔpyrE, respectively. Supernatants from 5-day cultures of the 251 
strains in trypticase glucose yeast broth supplemented with trypsin at 30 °C were used for toxin 252 
testing. A seroneutralization test using anti-E antitoxin which specifically neutralizes the toxic 253 
effects of BoNT/E was included. Neutralized (i.e. mixed with antitoxin) and untreated filtered 254 
supernatants were injected intraperitoneally in mice for evaluating the toxicity. Two animals were 255 
used per sample. Mice were observed at regular intervals for a period of 4 days for signs of 256 
botulism (ruffling of the fur, hypotonic abdomen, wasp-waist, difficulty in breathing, weakness 257 
of the limbs, and total paralysis) or death. Typical paralysis and/or death of the mice with 258 
prevention of these effects by the administration of antitoxin establishes a positive test for 259 
BoNT/E.  260 
Phenotypical analysis of wild type NCTC 11219 and NCTC 11219 bont/E mutants 261 
Unstressed growth. Wild type C. botulinum NCTC 11219 and mutants bontE211a::CT and 262 
ΔbontE::ermB were inoculated from single colonies in 1 ml TPGY broth in triplicate and 263 
incubated for 24h at 30 °C. The stationary cultures were diluted 5x103-fold in 50 mL TPGY (=t0), 264 
and incubated at 30 °C. Cell numbers were determined by plate counting on TPGY agar every 2h 265 
during 16h and again 8h later. 266 
Stressed growth. Overnight cultures of wild type and mutants were streaked in sixfold on RCM 267 
plates with different pH (5.7, 5.5, 5.2, 4.9; adjusted with HCl and measured before and after 268 
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autoclaving) or NaCl content (1.9%, 2.1%, 2.3%, 2.5%; taking into account that 0.5% NaCl is 269 
already present in RCM). The plates were incubated at 30 °C in an anaerobic workstation and 270 
colony formation was observed macroscopically for several days. Growth at lower temperatures 271 
was analysed in sixfold by streaking single colonies that were pregrown at 12 °C on RCM plates 272 
and incubating in AnaeroGen bags (Oxoid) at 8 °C and 12 °C. Colony formation was observed 273 
daily. 274 
Heat resistance of spores. Spore crops were made in triplicate from different colonies per strain 275 
and used within two weeks for this experiment. The initial spore count was determined by plate 276 
counting on TPGY after a heat treatment to inactivate remaining vegetative cells (65 °C, 10 min), 277 
but non-preheated samples were used for the heat inactivation experiment. Heat treatments were 278 
conducted in a heating block at 70 °C, 73 °C, 90 °C and 93 °C. At different time points, samples 279 
were taken and cooled immediately to stop inactivation, diluted in 0.85% NaCl, plated on TPGY 280 
and incubated at 30 °C for colony counting. For the treatments at 90 °C and 93 °C, lysozyme (10 281 
µg/ml; Carl Roth GmbH) was added to the plating medium. 282 
Statistical analysis  283 
To statistically assess the equivalence of unstressed growth, spore yield and spore heat resistance 284 
between the wild type and the two bont/E mutants, the two-tailed unpaired Student's t test was 285 
used with a significance level of 0.05. Since growth at low temperature was analysed in a ‘time to 286 
colony formation’ experiment, in this case a logistic regression model was fitted using the day, 287 
temperature and strain as predictor variables. The proposed model was highly significant (P-value 288 
whole model likelihood ratio test < 0.001; generalized R² = 0.9063) and showed no lack of fit (P-289 
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value lack of fit likelihood ratio test ~ 1), indicating it was suitable for testing the individual 290 
parameters.  291 
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RESULTS AND DISCUSSION 292 
C. botulinum NCTC 11219 is a group II type E strain isolated in 1979 from salmon after an 293 
outbreak of human botulism (33), of which we previously reported the genome sequence in four 294 
contigs (accession number JXMR01000001-JXMR01000004, 34). Here, we used this strain for 295 
the construction of atoxigenic mutants. The ClosTron system was used for insertional 296 
inactivation of the bont/E gene, whereas a new approach based on double homologous 297 
recombination using the selection markers pyrE and ermB was designed to create a bont/E 298 
deletion.  299 
Construction of insertion mutant C. botulinum NCTC 11219 bontE211a::CT  300 
Plasmid pMTL007C-E2:Cbo:bontE-211a, containing an intron retargeted to insert in bont/E, was 301 
transferred by conjugation to NCTC 11219. Since the intron contains a retrotransposition-302 
activated marker (RAM) based on the ermB gene, successful insertion of the intron in the genome 303 
is selectable by the expression of Em resistance. EmR clones were picked up and analysed by 304 
PCR and sequence analysis. The intron was correctly located in one clone at position 211 in the 305 
bont/E open reading frame with an antisense orientation of ermB relative to bont/E (Fig. 2, Fig. 3 306 
lane 2-3). Further analysing this clone by Y-linker PCR and sequencing of the PCR product, 307 
confirmed that only a single intron was present in the genome. The efficiency of the different 308 
steps in the ClosTron mutagenesis procedure was rather low. For conjugation of the ClosTron 309 
plasmid to NCTC 11219, several attempts were needed to obtain only two transconjugants. 310 
Similarly, several clones of transconjugants had to be restreaked to obtain 15 EmR colonies, and 311 
only one of these had the correct intron insertion. This confirms earlier statements in the literature 312 
that C. botulinum is less genetically tractable than most other clostridia (21, 35).  313 
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Construction of deletion mutant C. botulinum NCTC 11219 ΔbontE::ermB 314 
A deletion strategy to knockout bont/E was developed by combining different genetic tools that 315 
have not yet been used in gIICb, despite their success in other clostridia. Since effective suicide 316 
plasmids have not yet been described for C. botulinum, and given the reported low frequency of 317 
DNA transfer into gIICb, we chose to make use of pseudo-suicide plasmids for conjugation (30, 318 
36). These plasmids autonomously replicate but are segregationally unstable, providing the 319 
advantage to be lost more rapidly in the absence of selection after successful conjugation. A set 320 
of modular shuttle vectors, the pMTL80000 series, carrying four different gram-positive 321 
replicons was constructed by Heap et al. (2009) for use in the clostridia. We selected 322 
pMTL84151 with the pCD6 replicon from this set since this plasmid has the lowest stability in 323 
groups I and II C. botulinum (31, unpublished results). Another key element in the knockout 324 
strategy was the use of the pyrE gene as a bidirectional selection marker. First, pyrE was deleted 325 
from NCTC 11219 resulting in a 5-FOA resistant and uracil auxotroph strain (Fig. 3. Lane 4-5). 326 
Then the obtained ΔpyrE mutant was used as background to delete bont/E and replace it with an 327 
ermB marker. This was achieved by first conjugating pMTL84151_Δbont (Fig. 1) to the ΔpyrE 328 
mutant and selecting for Tm resistance, then streaking a transconjugant on medium containing 329 
both Em and 5-FOA. Since the plasmid expresses pyrE in trans, 5-FOA selects for its loss. 330 
Further, clones that lost the plasmid can only remain resistant to Em when the ermB gene was 331 
exchanged with the bont/E gene by double homologous recombination. Although this procedure 332 
selects for two events simultaneously, the frequency was sufficient to allow isolation of several 333 
colonies from a single streak. Obviously, the efficiency benefits from the low segregational 334 
stability of the plasmid. Loss of the plasmid was confirmed by loss of Tm resistance, and PCR 335 
and sequence analysis confirmed the replacement of bont/E by ermB (Fig. 2, Fig. 3 lane 6-7).  336 
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Finally, the pyrE deletion was restored to wild type by swapping pyrE and its flanking regions 337 
back to the chromosome by double homologous recombination with pMTL84151_WTpyr. To 338 
this end, the plasmid was first conjugated to NCTC 11219 ΔpyrE ΔbontE::ermB. The TmR 339 
transconjugants remained resistant to 5-FOA, which confirmed that pyrE was not expressed on 340 
pMTL84151_WTpyr. Since pyrE was cloned without its promotor (which is further upstream the 341 
pyr operon) on this plasmid, this result indicates that there is no leaky expression from plasmid 342 
promoters. In line with this observation, the transconjugants did not grow when they were plated 343 
on uracil-deficient medium, except for some rare colonies which showed normal growth when 344 
restreaked on the same medium. From these, subclones having lost the plasmid with a TmS 345 
phenotype were isolated. These were confirmed to have a wild type chromosomal pyrE allele, 346 
and were designated as NCTC 11219 ΔbontE::ermB. 347 
Mouse bioassays 348 
The presence of BoNT/E in culture supernatants of the NCTC 11219 wild type and the ΔpyrE 349 
strain was confirmed whereas no active toxin was detected for the bont/E insertion and deletion 350 
mutants. All mice injected with supernatant of wild type and ΔpyrE died within a day, while mice 351 
injected with supernatants of the mutants or supernatants from the bont/E wild type strains mixed 352 
with antitoxin E, survived till the end of observation at 4 days. Thus, loss of toxicity in both 353 
mutants was confirmed. In addition, the seroneutralization test using anti-E antitoxin confirmed 354 
that only one neurotoxin is produced by NCTC 11219, as was already predicted from the genome 355 
sequence (34). 356 
  357 
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Phenotypical analysis of wild type NCTC 11219 and NCTC 11219 bont/E mutants 358 
Nontoxic mutants of gIICb have the potential to greatly facilitate basic research and food 359 
challenge studies with this organism, provided that their properties related to growth, sporulation, 360 
survival and inactivation are not modified due to the knockout of the bont/E gene. Here, we 361 
compared the growth, sporulation and spore heat resistance of both constructed bont/E mutants 362 
and the wild type NCTC 11219 strain.  363 
Unstressed growth. The growth curves of the mutants and the wild type at 30 °C were very 364 
similar (Fig. 4). The DMFit software was used to determine the maximum growth rate µmax and 365 
the upper asymptote yend. The lag phase could not be evaluated because there were not enough 366 
points available to measure this accurately. No significant differences existed between µmax and 367 
yend of the wild type, ClosTron and ∆bontE mutant. The values were 0.7 +/- 0.2, 0.5 +/- 0.1, 0.4 368 
+/- 0.0 (log CFU/ml)/h for µmax, and 7.8 +/- 0.3, 8.0 +/- 0.0; 8.0 +/- 0.1 log CFU/ml for yend, 369 
respectively.  370 
Stressed growth. A quantitative comparison of growth under acidic, NaCl and low temperature 371 
stress was performed by assessing the time to colony formation on RCM plates. On acidified 372 
RCM, results of both mutants and wild type were identical in sixfold. Single colonies of 1 mm 373 
were visible after 24 h at pH 5.7 and after 30 h at pH 5.5, while pinpoint colonies appeared after 374 
72 h at pH 5.2. No colonies were formed at pH 4.9 up to 5 days. Under NaCl stress, all three 375 
strains showed clear single colonies in sixfold after 24 h at 1.9% and 2.1% NaCl. Unexpectedly, a 376 
small difference was observed at 2.3% NaCl between the ∆bontE::ermB strain compared to the 377 
wild type and ClosTron mutant. Strain ∆bontE::ermB formed clear 1 mm colonies after 24 h 378 
(sixfold) while those of the wild type and ClosTron mutant were pinpoint sized, and reached 1 379 
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mm only after 48 h (sixfold). No colonies appeared on 2.5% NaCl for any strain. The third stress 380 
condition tested, was growth at low temperature. Single colonies grown at 12 °C on RCM were 381 
restreaked in sixfold on RCM, then incubated at 12 °C and 8 °C, and the time to formation of 382 
colonies (1 mm) was registered. As opposed to the data for acid and NaCl stress, the time to 383 
colony formation at low temperature showed variability among the six replicates, as indicated in 384 
Table 2. A logistic regression model was fit on this data and showed that there was no significant 385 
effect of the strain (P-value effect likelihood ratio test 0.2388). Therefore, it can be concluded 386 
that there is no significant difference in growth at low temperature between the three 387 
strains.Spore production. Sporulation was performed in two-phase sporulation medium and 388 
observed regularly with phase contrast microscopy. Spore formation started within 72h for all 389 
strains. Spore counts were determined after 6 days by plate counting after inactivation of the 390 
vegetative cells at 65 °C for 10 min. No differences were observed in spore yield between wild 391 
type, bontE211a::CT and ΔbontE::ermB. Spore crops used for treatments at 90 °C/93 °C had a 392 
yield of 7.8 log +/- 0.1 CFU/ml, 8.1 +/- 0.3 CFU/ml and 7.9 +/- 0.1 CFU/ml, respectively. The 393 
spore crops used for heat treatments at 70 °C/73 °C all had the same yield, 7.6 log +/- 0.1 394 
CFU/ml. 395 
Spore heat resistance. In the analysis of spore heat resistance, we incorporated lysozyme in the 396 
recovery medium because this is known to increase the number of survivors of gIICb spores (37, 397 
38). This is because the cortex hydrolases which are required for spore germination are very heat 398 
sensitive, but can be substituted by exogenous lysozyme. The inactivation curves at 90 °C and 93 399 
°C showed a biphasic trend, with an initial rapid decrease of about 2 – 2.5 log, followed by a 400 
slower log-linear decrease (Fig. 5). This is in line with previous reports, and has been attributed 401 
to the existence of a lysozyme-impermeable and -permeable fraction in the spore population (38, 402 
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39). The decimal reduction times (D-values) were calculated only from the log-linear part, 403 
corresponding to the presumed lysozyme-permeable fraction. No differences were observed in 404 
the D90°C and D93°C between the three strains, suggesting that spore heat resistance is not affected 405 
by inactivation of bontE. In addition, we chose to report heat resistance without lysozyme in the 406 
recovery medium. This reduces the apparent heat resistance of the spores, and treatments were 407 
therefore performed at 70 °C and 73 °C. Inactivation was log-linear in this case (Fig. 6), and 408 
presumably correlates with the inactivation of the spore cortex hydrolases. The D70°C of the two 409 
mutants was slightly but significantly lower than that of wild type, but no difference was found 410 
between the D70°C of both mutants mutually. In contrast, the D73°C was not different between the 411 
three strains. Together, these results indicate that spore heat resistance is unaffected in the 412 
mutants, except for a small difference at 70 °C. Since this difference was observed both in the 413 
insertion and deletion mutant, it is unlikely to result from an accidental mutation unrelated to the 414 
knockout of the bont/E gene. One possible explanation is that the effect is due to a polar effect on 415 
one or more genes upstream or downstream of bont/E. However, given the gene context as shown 416 
in Fig. 2, it is difficult to imagine how the same polar effect could exist in both mutants. Finally, 417 
it cannot be excluded that the difference is a direct consequence of the abolition of toxin 418 
production. For example, it has been recently demonstrated that there is a regulatory link between 419 
sporulation and toxin production in gIICb strain Beluga via the Spo0A gene product (40). 420 
In conclusion, two strategies were employed in this study for obtaining a gIICb surrogate in 421 
which the bont/E gene is inactivated. Besides the well-known ClosTron system which generates 422 
insertional knockouts, we additionally developed a new approach based on double homologous 423 
recombination for the replacement of bont/E with an ermB cassette. Growth under unstressed and 424 
stressed conditions, sporulation and spore heat resistance of both mutants were compared with 425 
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the wild type NCTC 11219 and were unaffected, except for two properties where small 426 
differences were noted. Heat resistance of the spores at 70 °C was slightly lower for both 427 
mutants. In addition, growth of the deletion mutant in 2.3% NaCl was faster than for the other 428 
strains. The reason for the changes is currently unclear, and it could be of interest to investigate 429 
whether they are related to the loss of toxin production or to random mutations that have occurred 430 
during strain construction. However, since the deviations in the mutants are small compared to 431 
the natural strain-to-strain variation within gIICb, the nontoxic strains will be useful to 432 
investigate the safety of novel food processing and preservation techniques and for food 433 
challenge studies. Furthermore, the method for gene deletion developed in this work is a novel 434 
tool to construct nontoxic derivatives of type B and F gIICb strains as well as to inactivate any 435 
other gene in gIICb and other clostridia.   436 
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Fig. 1: Scheme showing the different fragments cloned between SbfI and AscI restriction sites of 557 
shuttle vector pMTL84151 (TmR) to create pMTL84151_Δbont (TmR EmR), that was used for 558 
replacing the bont/E gene for an ermB marker. The pfdx promotor (bended arrow) was derived 559 
from pMTL83353 and drives expression of pyrE, which was amplified from gDNA of NCTC 560 
11219. The 5’ and 3’ fragments of bont/E were also amplified from NCTC 11219 gDNA, and 561 
flank ermB derived from pMTL82254. 562 




Fig. 2: Schematic representation of A) bont/E with its upstream and downstream genes in C. 565 
botulinum NCTC 11219. Locus tags for all genes are also shown. B) Position of the ClosTron 566 
insert after 211th base of bont/E open reading frame in NCTC 11219 bontE211a::CT, with ermB 567 
antisense relative to bont/E. Also shown are primers bontE_F/bontE_R, annealing up- and 568 
downstream of the ClosTron target site, and primers upbontE_F/downbontE_R, annealing outside 569 
the loci used in double homologous recombination to delete bont/E. C) NCTC 11219 570 
ΔbontE::ermB, with bont/E deleted and replaced by ermB, confirmed by PCR using primers 571 
upbontE_F/downbontE_R. The position of the cloning primers bontE_5’F/bontE_5’R and 572 




Fig. 3: PCR analysis of different strain constructs. Lane 1 and 8: Molecular weight marker 575 
GeneRuler from Life Technologies; lane 2: NCTC 11219, bont/E fragment amplified with 576 
primers bontE_F/bontE_R (expected size: 410 bp); lane 3: NCTC 11219 bontE211a::CT, bont/E 577 
fragment with ClosTron insertion amplified with primers bontE_F/bontE_R (expected size: 2008 578 
bp); lane 4: NCTC 11219, pyrE region amplified with primers pyrE_5Fb/pyrE_3Rb (expected 579 
size: 3174 bp); lane 5: NCTC 11219 ΔpyrE, pyrE region amplified with primers 580 
pyrE_5Fb/pyrE_3Rb (expected size: 2474 bp); lane 6: NCTC 11219 ΔpyrE, bont/E region 581 
amplified with primers upbontE_F/downbontE_R (expected size: 6218 bp); lane 7: NCTC 11219 582 
∆bontE::ermB, bont/E region amplified with primers upbontE_F/downbontE_R (expected size: 583 
3449 bp). 584 





 Fig. 4: Growth in TPGY broth at 30 °C of wild type NCTC 11219, NCTC 11219 bontE211a::CT 588 
and NCTC 11219 ∆bontE::ermB determined by plate counting on TPGY. Averages +/- standard 589 
deviations are shown from three independent experiments.  590 




Fig. 5: Heat inactivation of spores of wild type NCTC 11219, NCTC 11219 bontE211a::CT and 593 
NCTC 11219 ∆bontE::ermB at 90 °C and 93 °C. Averages +/- standard deviation of three 594 
independent experiments are shown, as well as average D-values +/- standard deviation at 90 °C 595 
and 93 °C derived from the linear part of the curve. A common letter superscript at the same 596 






Fig. 6: Heat inactivation of spores of wild type NCTC 11219, NCTC 11219 bontE211a::CT and 601 
NCTC 11219 ∆bontE::ermB at 70 °C and 73 °C. Averages +/- standard deviation of three 602 
independent experiments are shown, as well as average D-values +/- standard deviation at 70 °C 603 
and 73 °C. A common letter superscript at the same temperature indicates that there is no 604 
significant difference. Since tailing occurred after 40 min at 70 °C and after 15 min at 73 °C, the 605 
corresponding data is not shown or used. 606 
 607 
  608 
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Table 1: PCR oligonucleotides used for cloning and construct verification. Restriction sites are 609 
underlined: KpnI (GGTACC), BamHI (GGATCC), XhoI (CTCGAG), NdeI (CATATG), SacI 610 
(GAGCTC) and SbfI (CCTGCAGG). The primers’ coordinates of NCTC 11219 are indicated in 611 
the third column, based on accession numbers JXMR01000001a or JXMR01000004b. 612 
Name Sequence (5'-3') Coordinate of 3’ end 
ClosTron 
bontE_F CCAGGCGGTTGTCAAGAATTTTAT 2298420a 






Y-linker primer TTTCTGCTCGAATTCAAGCTTCTAACGATGTACGGGGACACATG 
∆pyrE 
pyrE_5'F AACGGTACCCCACTACGTTCTCTCTTAGAGG 246521b 
pyrE_5'R AACGGATCCTGAGTTTAAGGTTTTTAGTTGG 247564b 
pyrE_3'F CATGGATCCTCCTCCCAAATTTCATAATGT 248312b 
pyrE_3'R CATCTCGAGTGTTTTATGCTGTGGTCCTG 249436b 
pyrE_5'Fb CCAACTTTATCAAAAGCTCAG 246369b 
pyrE_3'Rb CTAATACAGGAAAGCATGGC 249503b 
pMTL84151_mcsF AGGAAACAGCTATGACCG 
pMTL84151_mcsR GACGTTGTAAAACGACGG   
∆bontE 
pyrE11219_F AGGCATATGGAAGCATATAAAAAAGAG 248264b 
pyrE11219_R CTTGAGCTCCTACTTAGCACCATATTC 247627b 
bontE_5'F TAAGGTACCGTTATTGGAGATACATCCGG 2299564a 
bontE_5'R TAAGGATCCTGGCATATACAGCATCTCC 2298522a 
bontE_3'F TAAGGATCCAGAGATCATACAAACAGCAATGG 2294800a 
bontE_3'R TAACTCGAGCTATTCGAGAGAGCATTGGTCG 2293583a 
upbontE_F GAACTACTTATAAAAGAACAAACCTCACC 2299627a 
downbontE_R GAATGGATATCTTAGGATAATCATTCCAC 2293466a 
pMTL83353_F GAGCCTGCAGGATAAAAAAATTGTAG 
pMTL82254ermB_F  GTTGGATCCGAAGCAAACTTAAGAGTGTG 
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pMTL82254ermB_R TACGGATCCACATTCCCTTTAGTAACGTG   
 613 
Table 2: Growth at 12 °C and 8 °C of wild type NCTC 11219, NCTC 11219 bontE211a::CT and 614 
NCTC 11219 ∆bontE::ermB on RCM plates. Single colonies were restreaked in sixfold and the 615 
time to formation of 1 mm colonies was noted. 616 
Number of plates showing single colonies  
  at 12 °C at 8 °C 
  3 days 4 days 7 days 8 days 9 days 
NCTC 11219 5/6 6/6 4/6 5/6 6/6 
bontE211a::CT 4/6 6/6 4/6 6/6 6/6 










Name Sequence (5'-3') Coordinate of 3’ end 
ClosTron   
bontE_F CCAGGCGGTTGTCAAGAATTTTAT 2298420a 
bontE_R TCAAATAAATCAGGCTCTGCTCCC 2298057a 
RAM_F ACGCGTTATATTGATAAAAATAATAATAGTGGG  
RAM_R ACGCGTGCGACTCATAGAATTATTTCCTCCCG 
pCD6_F GTTGGGAGTAGTTGTGC  
pCD6_R ATGGTATCTCATTATTGGC  
ClosTron_R GTTTCAGACACTTTCCTCTATCGAG  
Y-linker primer TTTCTGCTCGAATTCAAGCTTCTAACGATGTACGGGGACACATG 
∆pyrE   
pyrE_5'F AACGGTACCCCACTACGTTCTCTCTTAGAGG 246521b 
pyrE_5'R AACGGATCCTGAGTTTAAGGTTTTTAGTTGG 247564b 
pyrE_3'F CATGGATCCTCCTCCCAAATTTCATAATGT 248312b 
pyrE_3'R CATCTCGAGTGTTTTATGCTGTGGTCCTG 249436b 
pyrE_5'Fb CCAACTTTATCAAAAGCTCAG 246369b 
pyrE_3'Rb CTAATACAGGAAAGCATGGC 249503b 
pMTL84151_mcsF AGGAAACAGCTATGACCG  
pMTL84151_mcsR GACGTTGTAAAACGACGG  
∆bontE   
pyrE11219_F AGGCATATGGAAGCATATAAAAAAGAG 248264b 
pyrE11219_R CTTGAGCTCCTACTTAGCACCATATTC 247627b 
bontE_5'F TAAGGTACCGTTATTGGAGATACATCCGG 2299564a 
bontE_5'R TAAGGATCCTGGCATATACAGCATCTCC 2298522a 
bontE_3'F TAAGGATCCAGAGATCATACAAACAGCAATGG 2294800a 
bontE_3'R TAACTCGAGCTATTCGAGAGAGCATTGGTCG 2293583a 
upbontE_F GAACTACTTATAAAAGAACAAACCTCACC 2299627a 
downbontE_R GAATGGATATCTTAGGATAATCATTCCAC 2293466a 
pMTL83353_F GAGCCTGCAGGATAAAAAAATTGTAG  
pMTL82254ermB_F  GTTGGATCCGAAGCAAACTTAAGAGTGTG  
pMTL82254ermB_R TACGGATCCACATTCCCTTTAGTAACGTG  
 
 Number of plates showing single colonies  
  at 12 °C at 8°C 
  3 d 4 d 7 d 8 d 9 d 
NCTC 11219 5/6 6/6 4/6 5/6 6/6 
bontE211a::CT 4/6 6/6 4/6 6/6 6/6 
∆bontE::ermB  3/6 6/6 3/6 4/6 6/6 
 
